Agreement signed for distribution in Japan

Aerocrine AB has announced that the company has entered into a distribution agreement with Chest M.I. Inc. to market and sell NIOX MINO, capable of enabling the fast and reliable management of airway inflammation and effective in the diagnosis, treatment and follow-up of asthma patients, throughout Japan.

You must be a subsciber to read this content

If you already subscribe, please sign-in now

Subscribe to Gas World

 

Get instant access to must-read content from top industry writers!

To access hundreds of features, subscribe today! Discover the in-depth content our subscribers receive every month by reading this week’s free feature. Join gasworld and become a subscriber to access all of our content online from just $270.